Kite Pharma, Inc. (Nasdaq: KITE), a leading cell therapy company, today announced that it has submitted a Marketing Authorization Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE